Activity value 80International Buyer&Supplier,Last transaction date:
2026-03-20
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for aspire pharmaceutical from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 63 transactions, with a transaction quantity of 539 and a transaction weight of 4654.
YearTransactionsQuantityWeight
202514438763229061
2026635394654
Bill of lading data
<
1/15
>
Trade date
2026/03/20
B/L No.
chkmctnyc2602988
Suppliers
hunan xiang li lai chemical co.ltd.
Buyers
aspire pharmaceutical
POLs
57017, xingang
PODs
4601, new york/newark area, newark, nj
aspire pharmaceutical is International Buyer&Supplier,
and primarily engages in the import and export business of products such as arts,pharmaceutical machinery,softgels.
According to the 52wmb.com global trade database, as of 2026-03-20, the company has completed 1310 international trades,
with its main trading regions covering india,other,costa rica etc.
The core products include HS84799040,HS54074490,HS84799090 etc,
often transported via new york,port newark, port newark nj etc,
and its main trading partners are arbes tools pvt ltd.,anita talegaonkar,jay ganesh enterprises.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on aspire pharmaceutical is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.